Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006782Source: DataRank Database

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response is a research paper published in Journal for ImmunoTherapy of Cancer (2023). On theSindex it has a DataRank of 0.776. It has been cited 21 times, with 20 citing works in its 1-hop citation network.

N/A

0.776DataRank · unranked

Scored on demand from live citation data

Open Access21 citations · 20 citing works in its network

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)OA: goldTopics (26)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 60%Citation Network 40%

Base Score Contribution

0.464

From this paper's citation signal

Citation Network Contribution

0.312

From 13 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 20 citers.

Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration
Journal of Hepatology202516 citations46 referencesContributes 0.062
Expression of HLA-DR and KLRG1 enhances the cytotoxic potential and cytokine secretion capacity of CD3+ T cells in tuberculosis patients
International Immunopharmacology20249 citations40 referencesContributes 0.058
Inhibition of tumor cell macropinocytosis driver DHODH reverses immunosuppression and overcomes anti-PD1 resistance
Immunity202514 citations62 referencesContributes 0.044
Evaluation of the clinical significance of lymphocyte subsets and myeloid suppressor cells in patients with renal carcinoma
Discover Oncology20243 citations34 referencesContributes 0.041
Reprogramming intratumoral T reg cells by morpholino-mediated splicing of FOXP3 for cancer immunotherapy
Science Immunology20254 citations52 referencesContributes 0.031

Authors (14)

Mingxuan Zhang ORCID,Matthew G. Chaimowitz,Shruti Bansal,Somnath Tagore ORCID,Aleksandar Obradović ORCID

Live enrichment

PubMed:37657842 PMC:PMC10476134

NIH/NCI Cancer Center

Grant: P30CA013696

NIH, National Cancer Institute

Grant: R01CA266446

NIH, National Cancer Institute

Grant: R01CA280414

NIH, National Cancer Institute

Grant: R21CA263381

NIH, National Cancer Institute

Grant: R37CA258829

NIH

Grant: TL1TR001875

NIH

Grant: UL1TR001873

NCI NIH HHS

Grant: R01 CA256188

National Institutes of Health

Grant: 4R01CA266446-04

The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy

National Institutes of Health

Grant: 1R21CA263381-01

Dissecting drug resistance in serial uveal melanoma biopsies using integrated, multi-modal single-cell profiling and novel machine learning tools.

National Institutes of Health

Grant: 5TL1TR001875-02

NRSA Training Core

National Institutes of Health

Grant: 3UL1TR001873-07S1

Clinical and Translational Science Award

National Institutes of Health

Grant: 5R37CA258829-04

Mechanisms of liver metastasis and associated resistance to immunotherapy

National Institutes of Health

Grant: 1R01CA280414-01

Multi-cellular interactions defining the human brain metastatic niche

National Institutes of Health

Grant: 3P30CA013696-21S1

CANCER CENTER CORE SUPPORT GRANT

Burroughs Wellcome Fund

Melanoma Research Alliance

V Foundation

Pershing Square Sohn Cancer Research Alliance

Columbia University

Prostate Cancer Foundation

goldLicense: cc-by-nc

publisherhttps://jitc.bmj.com/content/jitc/11/9/e006782.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2023-006782

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10476134/pdf/jitc-2023-006782.pdf

repositoryhttps://doaj.org/article/e9829ce92dbf4e9c97cb167d068ea152

Europe_PMChttps://europepmc.org/articles/PMC10476134

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

T-Lymphocyte SubsetsCD4-Positive T-LymphocytesHumansCarcinoma, Renal CellKidney NeoplasmsLectins, C-TypeReceptors, ImmunologicImmunotherapyBiomarkers

Keywords

ImmunotherapyRenal cell carcinomaCD4-Positive T-lymphocytesLymphocytes, Tumor-infiltratingImmune Checkpoint InhibitorsNeoplasms. Tumors. Oncology. Including cancer and carcinogensKidney NeoplasmsT-Lymphocyte SubsetsImmunotherapy BiomarkersHumansLectins, C-TypeReceptors, ImmunologicCarcinoma, Renal CellRC254-282Biomarkers